Abstract
Opportunities in Stem Cell Research and Commercialization' is the latest
addition to the Drug Discovery Series which analyzes the key factors impacting
the commercial exploitation of adult, fetal and embryonic stem cells. This new
report provides pharmaceutical companies with a clear assessment of
opportunities and challenges presented to them by the stem cell market. It
also provides vital insights into stem cell technologies and therapies that
have already proven to be successful and analyzes those which have potential
future value. The regulatory climate and proprietary landscape are discussed
enabling you to formulate and optimize your stem cell strategies and position
yourself for growth in this emerging market. Use this latest report to
recognize areas poised for growth in the market for tissue repair and
regeneration, identify potential alliance partners and plan a long-term growth
strategy to secure your leading position in this market.
View Cart
